Literature DB >> 22232100

Group visits hold great potential for improving diabetes care and outcomes, but best practices must be developed.

Robert E Burke1, Eileen T O'Grady.   

Abstract

A diagnosis of diabetes can require multiple changes in a person's behavior, diet, and lifestyle. Efforts to sustain these changes and manage this complex chronic disease can be difficult. Group visits, in which several patients meet together with a primary care provider and transdisciplinary team, have tremendous potential to improve health care quality, cost, and access. When group-based diabetes self-management education and a primary care visit occur within a single appointment, people with the disease can address multiple needs in one visit and take advantage of peer groups for support and motivation. A review of the literature demonstrates that the efficacy of group visits has a promising evidence base-but more needs to be learned about optimal group size and aspects of the model that should be standardized. An important first step is introducing a procedural code for group visits, so that providers and researchers can better track the efficacy of the group-visit model and develop best practices before the model is adopted systemwide.

Entities:  

Mesh:

Year:  2012        PMID: 22232100     DOI: 10.1377/hlthaff.2011.0913

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  28 in total

1.  Clinician-Reported Barriers to Group Visit Implementation.

Authors:  Beth A Careyva; Melanie B Johnson; Samantha A Goodrich; Kyle Shaak; Brian Stello
Journal:  J Prim Care Community Health       Date:  2016-02-16

2.  Influence of shared medical appointments on patient satisfaction: a retrospective 3-year study.

Authors:  Leonie Heyworth; Ronen Rozenblum; James F Burgess; Errol Baker; Mark Meterko; Debra Prescott; Zeev Neuwirth; Steven R Simon
Journal:  Ann Fam Med       Date:  2014-07       Impact factor: 5.166

3.  A crack in the wall: Chronic pain management in integrative group medical visits.

Authors:  Ariana Thompson-Lastad; Sara Rubin
Journal:  Soc Sci Med       Date:  2020-05-20       Impact factor: 4.634

4.  Sample size determinations for group-based randomized clinical trials with different levels of data hierarchy between experimental and control arms.

Authors:  Moonseong Heo; Alain H Litwin; Oni Blackstock; Namhee Kim; Julia H Arnsten
Journal:  Stat Methods Med Res       Date:  2016-07-11       Impact factor: 3.021

5.  Organizational Factors Influencing the Early Implementation Process of Diabetes Group Visits by Five Midwestern Community Health Centers: A Multisite Case Study Analysis.

Authors:  Priscilla A Barnes; Erin M Staab; Amanda Campbell; Cindy Schaefer; Michael T Quinn; Arshiya A Baig
Journal:  Popul Health Manag       Date:  2019-11-06       Impact factor: 2.459

6.  A Narrative Review of Diabetes Group Visits in Low-Income and Underserved Settings.

Authors:  Elizabeth M Vaughan; Craig A Johnston; Katherine R Arlinghaus; David J Hyman; John P Foreyt
Journal:  Curr Diabetes Rev       Date:  2019

Review 7.  Diabetes Management in Community Health Centers: a Review of Policies and Programs.

Authors:  A Taylor Kelley; Robert S Nocon; Matthew J O'Brien
Journal:  Curr Diab Rep       Date:  2020-02-06       Impact factor: 4.810

8.  Acceptability of Group Visits for Attention-Deficit Hyperactivity Disorder in Pediatric Clinics.

Authors:  Nerissa S Bauer; Nina Azer; Paula D Sullivan; Dorota Szczepaniak; Sarah M Stelzner; Stephen M Downs; Aaron E Carroll
Journal:  J Dev Behav Pediatr       Date:  2017-10       Impact factor: 2.225

Review 9.  Well-child care clinical practice redesign for young children: a systematic review of strategies and tools.

Authors:  Tumaini R Coker; Annika Windon; Candice Moreno; Mark A Schuster; Paul J Chung
Journal:  Pediatrics       Date:  2013-03       Impact factor: 7.124

10.  Diabetes group visits: integrated medical care and behavioral support to improve diabetes care and outcomes from a primary care perspective.

Authors:  Stephanie A Eisenstat; Kathleen Ulman; Allison L Siegel; Karen Carlson
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.